Skip to main content

Main menu

  • Articles
    • Current
    • Early Release
    • Archive
    • Rufus A. Lyman Award
    • Theme Issues
    • Special Collections
  • Authors
    • Author Instructions
    • Submission Process
    • Submit a Manuscript
    • Call for Papers - Intersectionality of Pharmacists’ Professional and Personal Identity
  • Reviewers
    • Reviewer Instructions
    • Call for Mentees
    • Reviewer Recognition
    • Frequently Asked Questions (FAQ)
  • About
    • About AJPE
    • Editorial Team
    • Editorial Board
    • History
  • More
    • Meet the Editors
    • Webinars
    • Contact AJPE
  • Other Publications

User menu

Search

  • Advanced search
American Journal of Pharmaceutical Education
  • Other Publications
American Journal of Pharmaceutical Education

Advanced Search

  • Articles
    • Current
    • Early Release
    • Archive
    • Rufus A. Lyman Award
    • Theme Issues
    • Special Collections
  • Authors
    • Author Instructions
    • Submission Process
    • Submit a Manuscript
    • Call for Papers - Intersectionality of Pharmacists’ Professional and Personal Identity
  • Reviewers
    • Reviewer Instructions
    • Call for Mentees
    • Reviewer Recognition
    • Frequently Asked Questions (FAQ)
  • About
    • About AJPE
    • Editorial Team
    • Editorial Board
    • History
  • More
    • Meet the Editors
    • Webinars
    • Contact AJPE
  • Follow AJPE on Twitter
  • LinkedIn
Research ArticleVIEWPOINTS

Counterfeit Medications and Their Negative Impacts on Health Care

Jack E. Fincham
American Journal of Pharmaceutical Education April 2014, 78 (3) 48; DOI: https://doi.org/10.5688/ajpe78348
Jack E. Fincham
School of Pharmacy, The University of Missouri Kansas City, Kansas City, Missouri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

INTRODUCTION

The problem and complexity of counterfeit medications on the health of patients globally is not a new issue. In 2008, Berman1 referenced efforts to identify and reduce the incidence and influence of counterfeit medications. Berman also pointed out that costs to society are impactful and include losses in employment, lost income and sales tax revenues, and expenses associated with increased trade deficits. Although not new, the counterfeit drug problem is becoming more and more problematic. Global estimates place counterfeit drug use at 10% of all prescription medications used.

Counterfeiters could care less who is impacted by their crimes. Cancer patients, for example, have been adversely impacted. In 2012, the US Food and Drug Administration (FDA) indicated 19 medical practices had purchased counterfeit versions of Roche’s cancer drug bevacizumab (Avastin) from an overseas supplier.2 You name the disease, counterfeit medications have impacted patient quality of life.

The scourge of medication counterfeiting is global in reach and effect. French researchers3 have pointed to not only harmful effects of counterfeit antibiotics upon individual patients, but also the global problems associated with the use of counterfeit medications and the emergence of bacterial resistance with a worldwide impact. After a study in the United Kingdom examining counterfeit medications and use, Jackson and colleagues4 urged pharmacists to report suspected incidents to regulatory agencies and to provide advice to patients in all settings regarding counterfeit medications and purchase of such via the Internet.

The involvement of organized crime is readily apparent in counterfeiting. Dégardin and colleagues5 noted that counterfeiting is a serious worldwide issue, and the networks manufacturing and distributing counterfeit medications are a component of organized crime. Medication counterfeiting is a serious worldwide issue, involving networks of manufacture and distribution that are an integral part of industrialized organized crime.

The FDA has been active in working to counteract the negativity of counterfeit use. The CD-3 (top), a small portable device invented by FDA scientists used to detect counterfeit items, is a new device that will allow for early identification of counterfeit medications.6 The broad scale use of this type of device will provide accessible identification of counterfeit medications early.

The Partnership for Safe Medication (www.safemedicines.org), an organization led by President Marvin Shepherd, PhD, from the University of Texas, has been an outspoken and effective voice in efforts to identify and combat counterfeit drug use and sale in the United States. This organization needs academic and professional support to continue its effective mission.

Educational outreach from our schools, community groups, the press (any and all forms of media), social networking options, and pharmacy organizations is necessary to provide resources and sources of information to the public on the importance of avoidance of the purchase and use of counterfeit medications. All members of the academy need to play a proactive and necessary role. The true impact of counterfeit medications is unknown, but the ways to reduce counterfeiting need to be known and properly advocated to influence this major quality of life deterrent now and in the future.

  • © 2014 American Association of Colleges of Pharmacy

REFERENCES

  1. 1.↵
    1. Berman B
    . Strategies to detect and reduce counterfeiting activity. Business Horiz. 2008;51(3):191-199.
    OpenUrl
  2. 2.↵
    1. Bate R,
    2. Attaran A
    . Counterfeit drugs: a growing global threat. The Lancet. 2012;379(9817):685.
    OpenUrl
  3. 3.↵
    1. Delepierre A,
    2. Gayot A,
    3. Carpentier A
    . Update on counterfeit antibiotics worldwide; public health risks. Med Mal Infect. 2012;42(6):247-255.
    OpenUrlCrossRefPubMed
  4. 4.↵
    US Food and Drug Administration. FDA invention fights counterfeit malaria drugs. FDA Consumer Health Information. April 2013:1-2.
  5. 5.↵
    1. Jackson G,
    2. Patel S,
    3. Khan S
    . Assessing the problem of counterfeit medications in the United Kingdom. Int J Clin Pract. 2012;66(3):241-250.
    OpenUrlPubMed
  6. 6.↵
    1. Dégardin K.,
    2. Roggo Y,
    3. Margot P
    . Understanding and fighting the medicine counterfeit market. J Pharm Biomed Anal. 2014;87:167-175.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

American Journal of Pharmaceutical Education
Vol. 78, Issue 3
17 Apr 2014
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Pharmaceutical Education.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Counterfeit Medications and Their Negative Impacts on Health Care
(Your Name) has sent you a message from American Journal of Pharmaceutical Education
(Your Name) thought you would like to see the American Journal of Pharmaceutical Education web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Counterfeit Medications and Their Negative Impacts on Health Care
Jack E. Fincham
American Journal of Pharmaceutical Education Apr 2014, 78 (3) 48; DOI: 10.5688/ajpe78348

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Counterfeit Medications and Their Negative Impacts on Health Care
Jack E. Fincham
American Journal of Pharmaceutical Education Apr 2014, 78 (3) 48; DOI: 10.5688/ajpe78348
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • INTRODUCTION
    • REFERENCES
  • Info & Metrics
  • PDF

Similar AJPE Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • In Memoriam: George H. Cocolas, PhD
  • Flexner, Educational Reform, and Pharmacy
  • Reflections for a Year of Caring and Understanding
Show more Viewpoints

Related Articles

  • No related articles found.
  • Google Scholar

Home

  • AACP
  • AJPE

Articles

  • Current Issue
  • Early Release
  • Archive

Instructions

  • Author Instructions
  • Submission Process
  • Submit a Manuscript
  • Reviewer Instructions

About

  • AJPE
  • Editorial Team
  • Editorial Board
  • History
  • Contact

© 2022 American Journal of Pharmaceutical Education

Powered by HighWire